Results 21 to 30 of about 21,745 (193)

Histopathology of drug eruptions-general criteria, common patterns, and differential diagnosis

open access: yesDermatology Practical & Conceptual, 2011
Drug eruptions are among the most common inflammatory diseases of the skin and also among those biopsied most often. Yet, the value of histopathologic examination of drug eruptions has often been disputed.
Wolfgang Weyers, Dieter Metze
doaj   +1 more source

Cetirizine-induced fixed drug eruption: a case report and review of literature

open access: yesSri Lanka Journal of Medicine, 2020
Cetirizine is a commonly used antihistamine in the management of itchy dermatoses, allergic reactions and cutaneous drug eruptions. However, it can rarely be the causative agent in cutaneous drug eruptions.
Sanjeewani Fonseka, Brabaharan Subhani
doaj   +1 more source

Drug Eruption [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1933
The use of gold and bismuth salts is sometimes followed by the development of a toxic rash. In the case herein reported a rash which simulated both pityriasis rosea and erythema multiforme developed following the extended use of gold sodium thiosulphate and again following medication with bismuth salicylate.
openaire   +3 more sources

A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin

open access: yesCanadian Journal of Gastroenterology, 2009
Drug-induced cutaneous eruptions are named among the most common side effects of many medications. Thus, cutaneous drug eruptions are a common cause of morbidity and mortality, especially in hospital settings.
Nisha Mistry   +2 more
doaj   +1 more source

Case Report: Nicolau syndrome due to etofenamate injection [version 1; referees: 2 approved]

open access: yesF1000Research, 2017
Nicolau syndrome, also known as embolia cutis medicomentosa, is a rare complication characterized by tissue necrosis that occurs after injection of drugs.
Emin Ozlu   +6 more
doaj   +1 more source

Vemurafenib and cutaneous adverse events - report of five cases [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
Vemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib.
Giselle de Barros Silva   +5 more
doaj   +1 more source

Drug eruption by antihistamine mistaken for chronic urticaria in a child [PDF]

open access: yesKorean Journal of Pediatrics, 2019
Although rare, antihistamines can cause adverse effects, including drug-induced eruptions or anaphylaxis. A 4-year-old child visited the pediatric department of a hospital for skin eruptions after administration of antihistamines, (e.g., ucerax ...
Gun Moo Lee   +5 more
doaj   +1 more source

Retrospective analysis of drug eruptions in 89 cases

open access: yesPifu-xingbing zhenliaoxue zazhi
Objective To investigate the clinical features of drug eruptions and the most common causative drugs in inpatients in order to provide a reference for the diagnosis and the treatment of drug eruptions.
ZHANG Yali   +5 more
doaj   +1 more source

Maculopapular drug eruptions

open access: yes, 2007
Maculopapular (exanthematous) reactions are the most common adverse drug eruptions affecting the skin. Several studies indicate that immunological mechanisms including cytotoxic T cells (CD4+ > CD8+), both type 1 (e.g. IFN- γ ) and type 2 (e.g.
Nikhil Yawalkar, Yawalkar, Nikhil
core   +1 more source

Common adverse cutaneous drug reaction patterns and the causative drugs in Malaysia

open access: yesSouth African Family Practice, 2015
Background: Patients with adverse cutaneous drug reactions (ACDRs) are frequently referred from primary care to tertiary centres for further management.
N. H. Talib, M. Leelavathi, Z. Hamzah
doaj   +1 more source

Home - About - Disclaimer - Privacy